Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial
Pfizer Inc (PFE.N) and BioNTech SE (22UAy.F) said on Tuesday they have begun delivering doses of their experimental coronavirus vaccines for initial human testing in the United States.
- Region:
- World
- Category:
- Technology
- Author/s:
- By Reuters
